Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer’s disease neurodegeneration

Alzheimer’s disease (AD) is the most common form of dementia in the elderly. The vast majority of cases are not linked to a known genetic defect and the molecular mechanisms underlying AD pathogenesis are still elusive. Evidence suggests that mitochondrial dysfunction is a prominent feature of the d...

Full description

Bibliographic Details
Main Authors: Tiziana eCasoli, Liana eSpazzafumo, Giuseppina eDi Stefano, Fiorenzo eConti
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-07-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fnagi.2015.00142/full
_version_ 1811331139956113408
author Tiziana eCasoli
Liana eSpazzafumo
Giuseppina eDi Stefano
Fiorenzo eConti
Fiorenzo eConti
author_facet Tiziana eCasoli
Liana eSpazzafumo
Giuseppina eDi Stefano
Fiorenzo eConti
Fiorenzo eConti
author_sort Tiziana eCasoli
collection DOAJ
description Alzheimer’s disease (AD) is the most common form of dementia in the elderly. The vast majority of cases are not linked to a known genetic defect and the molecular mechanisms underlying AD pathogenesis are still elusive. Evidence suggests that mitochondrial dysfunction is a prominent feature of the disease, and that mitochondrial DNA (mtDNA) alterations may represent a possible starting point of the pathophysiological cascade. Although specific mtDNA alterations have been reported in AD patients both in brain and peripheral tissues, such as D-loop mutations, 4977-bp deletion and poly-C tract D310 cytosine insertion, a generalized subtle allelic shift has also been demonstrated. This shift is significant for a few nucleotide positions (nps), but it is also detectable for most nps, although at a lower level. As single allelic substitutions can unlikely be determinant, it is proposed that the combination of all of them could lead to a less efficient oxidative phosphorylation, thus influencing AD development and course.
first_indexed 2024-04-13T16:14:43Z
format Article
id doaj.art-1e19521a2a434eaead42c58c45acd119
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-04-13T16:14:43Z
publishDate 2015-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-1e19521a2a434eaead42c58c45acd1192022-12-22T02:40:05ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652015-07-01710.3389/fnagi.2015.00142145263Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer’s disease neurodegenerationTiziana eCasoli0Liana eSpazzafumo1Giuseppina eDi Stefano2Fiorenzo eConti3Fiorenzo eConti4INRCA IRCCSINRCA IRCCSINRCA IRCCSUniversita Politecnica delle MarcheINRCA IRCCSAlzheimer’s disease (AD) is the most common form of dementia in the elderly. The vast majority of cases are not linked to a known genetic defect and the molecular mechanisms underlying AD pathogenesis are still elusive. Evidence suggests that mitochondrial dysfunction is a prominent feature of the disease, and that mitochondrial DNA (mtDNA) alterations may represent a possible starting point of the pathophysiological cascade. Although specific mtDNA alterations have been reported in AD patients both in brain and peripheral tissues, such as D-loop mutations, 4977-bp deletion and poly-C tract D310 cytosine insertion, a generalized subtle allelic shift has also been demonstrated. This shift is significant for a few nucleotide positions (nps), but it is also detectable for most nps, although at a lower level. As single allelic substitutions can unlikely be determinant, it is proposed that the combination of all of them could lead to a less efficient oxidative phosphorylation, thus influencing AD development and course.http://journal.frontiersin.org/Journal/10.3389/fnagi.2015.00142/fullAgingMutationAlzheimer’s diseasemitochondrial DNAallele
spellingShingle Tiziana eCasoli
Liana eSpazzafumo
Giuseppina eDi Stefano
Fiorenzo eConti
Fiorenzo eConti
Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer’s disease neurodegeneration
Frontiers in Aging Neuroscience
Aging
Mutation
Alzheimer’s disease
mitochondrial DNA
allele
title Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer’s disease neurodegeneration
title_full Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer’s disease neurodegeneration
title_fullStr Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer’s disease neurodegeneration
title_full_unstemmed Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer’s disease neurodegeneration
title_short Role of diffuse low-level heteroplasmy of mitochondrial DNA in Alzheimer’s disease neurodegeneration
title_sort role of diffuse low level heteroplasmy of mitochondrial dna in alzheimer s disease neurodegeneration
topic Aging
Mutation
Alzheimer’s disease
mitochondrial DNA
allele
url http://journal.frontiersin.org/Journal/10.3389/fnagi.2015.00142/full
work_keys_str_mv AT tizianaecasoli roleofdiffuselowlevelheteroplasmyofmitochondrialdnainalzheimersdiseaseneurodegeneration
AT lianaespazzafumo roleofdiffuselowlevelheteroplasmyofmitochondrialdnainalzheimersdiseaseneurodegeneration
AT giuseppinaedistefano roleofdiffuselowlevelheteroplasmyofmitochondrialdnainalzheimersdiseaseneurodegeneration
AT fiorenzoeconti roleofdiffuselowlevelheteroplasmyofmitochondrialdnainalzheimersdiseaseneurodegeneration
AT fiorenzoeconti roleofdiffuselowlevelheteroplasmyofmitochondrialdnainalzheimersdiseaseneurodegeneration